SANTA CLARA, Calif., Dec. 04, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex ...
At EuroPCR 2026, experts highlighted major advances in the treatment of previously untreatable calcified coronary lesions.
Initial FIH procedures launch FastWave's multi-center feasibility study evaluating the safety and performance of its laser-based coronary IVL platform. MINNEAPOLIS, June 3, 2025 /PRNewswire/ -- ...
Cagent Vascular today announced the first-in-human cases with its Serranator Sonic IVL system alongside significant funding.
SANTA CLARA, Calif., June 08, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex ...
SANTA CLARA, Calif. and SINGAPORE, May 23, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified ...
Calcified femoropopliteal arterial disease remains a major challenge in endovascular therapy. Vessel preparation technologies have emerged to improve ...
SANTA CLARA, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular ...
SAN FRANCISCO — Two different balloon devices developed for the treatment of calcified coronary lesions were found noninferior to intravascular lithotripsy (IVL) at a lower cost in separate major ...
HACKENSACK, N.J. (CBSNewYork)-- One of the most common heart procedures done in this country is a called a coronary angioplasty. A balloon opens up a heart artery and usually a stent is placed to keep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results